InsidersTradesSigma
Follow the 삼진제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 삼진제약 has recorded 80 public disclosures. The latest transaction was reported on 10 July 2026 (Other). Among the most active insiders: 전상진. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 80 declarations
Samjin Pharmaceutical is a South Korean pharmaceutical company focused on the research, development, and manufacturing of medications. It is listed on the Korea Exchange, XKRX.